CompletedNot Applicable

Idiopathic Recurrent Acute Pancreatitis (IRAP)

United States50 participantsStarted 2010-06

Plain-language summary

The purpose of this study is to collect standardized data on the diagnosis and management of idiopathic (unknown cause) recurrent acute pancreatitis. The intent is to collect data for at least five years to obtain information regarding long-term outcomes and obtain comparative effectiveness data.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 years or older
✓. Able to provide consent
✓. More than one documented episode of pancreatitis (\>3 fold elevation of amylase and or lipase with abdominal pain or with body imaging consistent with pancreatitis: need two of the three)
✓. Subjects with abdominal pain and enzyme elevation which is \<3 fold above normal or absence of imaging findings: these subjects who are undergoing endoscopic interventions but do not fit the "classic criteria" for pancreatitis will be included but the analysis of data of these subjects would be done separately.

Exclusion criteria

✕. Unable to give informed consent.
✕. Definite evidence of biliary or alcoholic pancreatitis.
✕. Clear evidence of hypertriglyceridemia-induced pancreatitis (triglycerides \>1,000 mg/dl).
✕. Post-ERCP pancreatitis, drug-induced pancreatitis, or any identifiable cause for pancreatitis.
✕. History of pancreatic surgery.

What they're measuring

IDIOPATHIC RECURRENT ACUTE PANCREATITIS (IRAP)

Timeframe: The goal is to recruit 1000 subjects in 5 years.

Trial details

NCT IDNCT01133535

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-12

View on ClinicalTrials.gov More Pancreatitis trials